ME Therapeutics Holdings Inc.

C$1.05As of Sun 8 Nov 2026, 12:00 UTC
CSE:METXHealthcare
Country Canada
PE (Fwd) •••
TSR 3Y CAGR 18.57%
Div yield —
ROE (111.03%)
Biotechnology
Beta (5Y) 0.17
PE TTM —
TSR TTM (79.00%)
Mkt cap C$31.91M
ROIC (74.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.08
3.02%
(68.51%)
Hold 8|12|7|1|4
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.01
0.01
0.01
0.01
12.57%
20.46%
24.11%
11.37%
Revenue$M
1.458
1.489
1.512
1.552
1.02%
4.67%
6.78%
7.50%
Peers (US$22.58M)
Cap (US$)
PE
25.64M
—
24.83M
—
19.32M
—
22.58M
12.09x
Capital
TTM
5Y
10Y
Leveragex
0.503
(0.255)
(0.242)
EBIT/Intx
2.239
2.703
2.578
Own earn%
39.05
(84.17)
(117.15)
Sh yield%
4.50
34.40
35.11
Owners
Insiders/Inst%
13.72
31.18
Short interest%
2.09
SBC / revenue%
3.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
16